GARDASIL®9

A Trial to Evaluate Tolerability and Immunogenicity of V540D in Healthy Adults (V540D-004)

A Clinical Study of V540A in Healthy Female Participants (V540A-005)

Efficacy of Human Papillomavirus (HPV) Vaccination to Prevent Infection Among Women Living With HIV.

Assessing Durable Antibody Response to HPV Vaccination

HPV Vaccine Reduced Dose

Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women

Immunogenicity of the 9vHPV Vaccination 2-dose Regimen Among Children 4 to 8 Years Old

HPV Vaccination Study in Postpartum Women

Immunogenicity of a Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58)Vaccine(E.Coli) Versus Gardasil®9 in Healthy Females 18-26 Years of Age

Occupational Exposure to Human Papilloma Virus (HPV) and Prophylactic Vaccination

A Phase II Study of SCT1000 in Healthy Women Aged 18 to 45 Years

Postpartum HPV Vaccination

A Phase I Safty and Immunogenicity Study of SCT1000 in Healthy Women Aged 18 to 45 Years

Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden

Impact on Disease Relapse of HPV Vaccination in Women Treated With LEEP for Cervical Intraepithelial Neoplasia. HOPE9